ぶどう膜炎治療の世界市場

• 英文タイトル:Global Market Study on Uveitis Treatment: Acceptance for Local Steroid Implants on a Visible Rise

Global Market Study on Uveitis Treatment: Acceptance for Local Steroid Implants on a Visible Rise「ぶどう膜炎治療の世界市場」(市場規模、市場予測)調査レポートです。• レポートコード:PMR-DC070
• 出版社/出版日:Persistence Market Research / 2019年9月17日
• レポート形態:英文、PDF、163ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Individual User(1名用)¥529,200 (USD4,900)▷ お問い合わせ
  Multi User(5名用)¥820,800 (USD7,600)▷ お問い合わせ
  Corporate User(企業用)¥1,144,800 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、ぶどう膜炎治療の世界市場について調査・分析し、市場概要、市場力学、治療種類別(コルチコステロイド、免疫抑制剤、モノクローナル抗体、周期性麻痺薬、抗ウイルス薬、抗真菌薬、鎮痛薬、抗生物質)分析、疾患別(前部ブドウ膜炎、後部ブドウ膜炎、中間部ブドウ膜炎、膜炎)分析、原因別(感染性ぶどう膜炎、非感染性ぶどう膜炎)分析、流通チャンネル別(病院薬局、小売薬局、オンライン薬局、ドラッグストア)分析、地域別(北米、ラテンアメリカ、ヨーロッパ、アジア太平洋、中東・アフリカ)分析、競合分析などを含め次の構成でお届け致します。

・エグゼクティブサマリー
・市場概要
・市場力学
・ぶどう膜炎治療の世界市場:治療種類別(コルチコステロイド、免疫抑制剤、モノクローナル抗体、周期性麻痺薬、抗ウイルス薬、抗真菌薬、鎮痛薬、抗生物質)
・ぶどう膜炎治療の世界市場:疾患別(前部ブドウ膜炎、後部ブドウ膜炎、中間部ブドウ膜炎、膜炎)
・ぶどう膜炎治療の世界市場:原因別(感染性ぶどう膜炎、非感染性ぶどう膜炎)
・ぶどう膜炎治療の世界市場:流通チャンネル別(病院薬局、小売薬局、オンライン薬局、ドラッグストア)
・ぶどう膜炎治療の世界市場:地域別(北米、ラテンアメリカ、ヨーロッパ、アジア太平洋、中東・アフリカ)
・競合分析

Persistence Market Research (PMR) recently published a market study on the global market for Uveitis treatment. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the uveitis treatment market structure. The market study presents exclusive information about how the uveitis treatment market will grow during the forecast period of 2019-2029.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes pipeline analysis which comprises of detail information about the ongoing clinical trials across all regions. There other information contains total number of molecules, which are under clinical trials for uveitis treatment. This information helps in deep understanding of the future scope of different drugs available for uveitis treatment by drug manufacturers, researchers and medical practitioners.

The other information contains incidence, distribution, possible control of diseases and other factors relating to the health due to uveitis diseases. The other information contains market size in value analysis, which includes year wise growth of uveitis treatment during the forecasted period. This information can help readers understand the quantitative growth prospects of the uveitis treatment market during the forecast period. The study is relevant for drug manufacturers, distributors, wholesalers and regulatory experts and can help them in developing appropriate strategies to grow in the market.

The study also includes statistics as well as facts related to macro as well as microeconomic factors that are impacting developments in the market. It also offers actionable insights based on future trends in the uveitis treatment market. Furthermore, new entrants in the uveitis treatment market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

Key Questions Answered in PMR’s Uveitis Treatment Market Report

Which regions will continue to remain the most profitable regional markets for uveitis treatment market players?
Which factors will induce a change in the demand for uveitis treatment during the assessment period?
How will changing trends impact the uveitis treatment market?
How can market players capture the low-hanging opportunities in the uveitis treatment market in developed regions?
Which companies are leading the uveitis treatment market?
What are the winning strategies of stakeholders in the uveitis treatment market to upscale their position in this landscape?
Uveitis Treatment Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the uveitis treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analyst ensure accuracy and reliability of conclusions.

Secondary resources referred to analyst during market study include statistics from government healthcare organizations, medicines journals, research journals, press release, annual reports, white papers, directories and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the uveitis treatment market, and makes PMR’s projection on the growth prospects of the uveitis treatment market more accurate and reliable.

レポート目次

1. Executive Summary
1.1. Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Dynamics
3.1. Macro-Economic Factors
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity Analysis
3.1.4. Trends
3.1.5. Forecast Factors – Relevance and Impact
3.1.6. Pipeline Analysis
3.1.7. Disease Epidemiology
3.1.8. Regulatory Scenario
4. Global Uveitis Treatment Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
4.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
4.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
4.2.3. Market Value Comparison
5. Global Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Treatment Type
5.1. Introduction / Key Findings
5.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2014-2018
5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2019 – 2029
5.3.1. Corticosteroids
5.3.2. Immunosuppressant
5.3.3. Monoclonal Antibodies
5.3.4. Cycloplegic Agents
5.3.5. Antivirals
5.3.6. Antifungals
5.3.7. Analgesic
5.3.8. Antibiotics
5.4. Market Attractiveness Analysis By Treatment Type
6. Global Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Diseases Type
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Diseases, 2014-2018
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Diseases, 2019 – 2029
6.3.1. Anterior Uveitis
6.3.2. Posterior Uveitis
6.3.3. Intermediate Uveitis
6.3.4. Panuveitis
6.4. Market Attractiveness Analysis By Diseases
7. Global Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Cause
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Cause, 2014-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cause, 2019 – 2029
7.3.1. Infectious Uveitis
7.3.2. Non-infectious Uveitis
7.4. Market Attractiveness Analysis By Cause
8. Global Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.3.4. Drug Stores
8.4. Market Attractiveness Analysis By Distribution Channel
9. Global Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East & Africa
9.4. Market Attractiveness Analysis By Region
10. North America Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Treatment Type
10.3.3. By Diseases Type
10.3.4. By Cause
10.3.5. By Distribution Channel
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Treatment Type
10.4.3. By Diseases Type
10.4.4. By Cause
10.4.5. By Distribution Channel
11. Latin America Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Rest of Latin America
11.3.2. By Treatment Type
11.3.3. By Diseases Type
11.3.4. By Cause
11.3.5. By Distribution Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Treatment Type
11.4.3. By Diseases Type
11.4.4. By Cause
11.4.5. By Distribution Channel
12. Europe Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. Italy
12.3.1.3. France
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. Russia
12.3.1.7. Rest of Europe
12.3.2. By Treatment Type
12.3.3. By Diseases Type
12.3.4. By Cause
12.3.5. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Treatment Type
12.4.3. By Diseases Type
12.4.4. By Cause
12.4.5. By Distribution Channel
13. Asia Pacific Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
13.3.1. By Country
13.3.1.1. Japan
13.3.1.2. China
13.3.1.3. India
13.3.1.4. Australia & New Zealand
13.3.2. By Treatment Type
13.3.3. By Diseases Type
13.3.4. By Cause
13.3.5. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Treatment Type
13.4.3. By Diseases Type
13.4.4. By Cause
13.4.5. By Distribution Channel
14. Middle East and Africa Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
14.3.1. By Country
14.3.1.1. GCC
14.3.1.2. South Africa
14.3.1.3. North Africa
14.3.1.4. Rest of MEA
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Treatment Type
14.4.3. By Diseases Type
14.4.4. By Cause
14.4.5. By Distribution Channel
15. Competition Analysis
15.1. Competition Dashboard
15.2. Competition Deep Dive
15.2.1. Allergan, Inc.
15.2.1.1. Overview
15.2.1.2. Product Portfolio
15.2.1.3. Profitability by Market Segments (Product/Channel/Region)
15.2.1.4. Sales Footprint
15.2.1.5. Strategy Overview
15.2.1.5.1. Marketing Strategy
15.2.1.5.2. Product Strategy
15.2.1.5.3. Channel Strategy
15.2.2. Novartis AG
15.2.2.1. Overview
15.2.2.2. Product Portfolio
15.2.2.3. Profitability by Market Segments (Product/Channel/Region)
15.2.2.4. Sales Footprint
15.2.2.5. Strategy Overview
15.2.2.5.1. Marketing Strategy
15.2.2.5.2. Product Strategy
15.2.2.5.3. Channel Strategy
15.2.3. Bausch Health Inc.
15.2.3.1. Overview
15.2.3.2. Product Portfolio
15.2.3.3. Profitability by Market Segments (Product/Channel/Region)
15.2.3.4. Sales Footprint
15.2.3.5. Strategy Overview
15.2.3.5.1. Marketing Strategy
15.2.3.5.2. Product Strategy
15.2.3.5.3. Channel Strategy
15.2.4. AbbVie Inc.
15.2.4.1. Overview
15.2.4.2. Product Portfolio
15.2.4.3. Profitability by Market Segments (Product/Channel/Region)
15.2.4.4. Sales Footprint
15.2.4.5. Strategy Overview
15.2.4.5.1. Marketing Strategy
15.2.4.5.2. Product Strategy
15.2.4.5.3. Channel Strategy
15.2.5. Eyegate Pharmaceuticals, Inc.
15.2.5.1. Overview
15.2.5.2. Product Portfolio
15.2.5.3. Profitability by Market Segments (Product/Channel/Region)
15.2.5.4. Sales Footprint
15.2.5.5. Strategy Overview
15.2.5.5.1. Marketing Strategy
15.2.5.5.2. Product Strategy
15.2.5.5.3. Channel Strategy
15.2.6. Alimera Science Inc.
15.2.6.1. Overview
15.2.6.2. Product Portfolio
15.2.6.3. Profitability by Market Segments (Product/Channel/Region)
15.2.6.4. Sales Footprint
15.2.6.5. Strategy Overview
15.2.6.5.1. Marketing Strategy
15.2.6.5.2. Product Strategy
15.2.6.5.3. Channel Strategy
15.2.7. EyePoint Pharmaceuticals
15.2.7.1. Overview
15.2.7.2. Product Portfolio
15.2.7.3. Profitability by Market Segments (Product/Channel/Region)
15.2.7.4. Sales Footprint
15.2.7.5. Strategy Overview
15.2.7.5.1. Marketing Strategy
15.2.7.5.2. Product Strategy
15.2.7.5.3. Channel Strategy
15.2.8. Santen Pharmaceuticals
15.2.8.1. Overview
15.2.8.2. Product Portfolio
15.2.8.3. Profitability by Market Segments (Product/Channel/Region)
15.2.8.4. Sales Footprint
15.2.8.5. Strategy Overview
15.2.8.5.1. Marketing Strategy
15.2.8.5.2. Product Strategy
15.2.8.5.3. Channel Strategy
16. Assumptions and Acronyms Used
17. Research Methodology

List of Tables

Table 01: Uveitis Treatment Market Value (US$ Mn) Growth Comparison
Table 02: Global Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 03: Global Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases Type
Table 04: Global Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 05: Global Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 06: Global Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Region
Table 07: North America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 08: North America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 09: North America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases
Table 10: North America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 11: North America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 12: Latin America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 13: Latin America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 14: Latin America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases
Table 15: Latin America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 16: Latin America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 17: Europe Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 18: Europe Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 19: Europe Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases
Table 20: Europe Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 21: Europe Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 22: Asia Pacific Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 23: Asia Pacific Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 24: Asia Pacific Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases
Table 25: Asia Pacific Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 26: Asia Pacific Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 27: Middle East & Africa Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 28: Middle East & Africa Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 29: Middle East & Africa Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases
Table 30: Middle East & Africa Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 31: Middle East & Africa Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel


• 英文レポート名:Global Market Study on Uveitis Treatment: Acceptance for Local Steroid Implants on a Visible Rise
• 日本語訳:ぶどう膜炎治療の世界市場
• レポートコード:PMR-DC070お問い合わせ(見積依頼・ご注文・質問)